Last Updated: 12 December 2025
Breast Cancer Network Australia (BCNA) responds to the recent study published in the BMJ by Nickel et al which focusses on potential adverse outcomes associated with informing women about their breast density.
The BMJ study concluded that ‘women notified of their dense breasts felt anxious and confused, did not feel more informed to make decisions about their breast health, and wanted to be guided by their general practitioner.' It also stated that 'notification of breast density as part of population-based breast screening may have adverse outcomes, including additional consultation burden on general practitioners'.
BCNA is concerned about the conclusions drawn from this study. The suggestion that informing women of clinically relevant information about their bodies should be reconsidered because it may increase GP burden is deeply troubling. Women seeking guidance from their GP is not an ‘adverse outcome’—it is a cornerstone of safe, person-centered healthcare.
“The idea that informing women of clinically relevant information could lead to ‘adverse outcomes’ is deeply problematic. The real risk lies in not informing women. Withholding information limits choice, undermines trust, and ultimately disempowers those we aim to support. BCNA strongly supports women receiving comprehensive information and discussing their breast health with their GP.”
To use potential GP burden as a rationale for not notifying women of their breast density is fundamentally at odds with contemporary principles of informed consent, transparency, and shared decision-making. Withholding information to reduce pressure on the health system sets a dangerous precedent and risks undermining women’s autonomy and trust in screening programs.
BCNA strongly supports BreastScreen Australia’s policy position that women should be informed in writing of their mammographic density, and that they are encouraged to discuss with their GP how breast density affects their approach to early detection, in the context of their risk factors, personal circumstances, and preferences.
Significant national policy developments now support this approach. BreastScreen Australia’s updated Position Statement on mammographic density recommends written notification to women and is strengthened by the Australian Government’s GP Breast Density Guidance which was developed in consultation with the Royal Australian College of General Practitioners. BCNA consumer representatives contributed to the co-design of this guidance to ensure that women's lived experience shaped clear, consistent, evidence-based pathways for screening and follow-up.
BCNA will continue to advocate for transparency, equity, and informed choice - because women deserve nothing less.
As someone whose own cancer was missed on a mammogram due to dense breast tissue, I’m deeply aware of how vital it is for women to have this information. While it’s disappointing that the study’s results were framed negatively, the actual findings that informed women’s knowledge increased, as did their intention to consult their GP and to continue screening in the future highlight the importance of notifying women. In the end, it’s about empowering women with the knowledge we need to make informed decisions about our health
If this research, media or response has raised questions for you Breast Cancer Network Australia is here. We can provide you with the trusted place to turn for accurate information about breast density, breast cancer risk and importantly all your options.
Call our Helpline on 1800 500 258 or head to the breast density information on our website
access personalised resources and track your side effects
start or join discussions in our Online Network
register as a healthcare professional